Adalimumab in severe and acute sciatica: A multicenter, randomized, double-blind, placebo-controlled trial

Stéphane Genevay, Sebastien Viatte, Axel Finckh, Pascal Zufferey, Federico Balagué, Cem Gabay

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'Adalimumab in severe and acute sciatica: A multicenter, randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science